#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epidermolysis bullosa Angiosarcoma non-metastatic Activated PI3 kinase delta syndrome Chronic graft versus host disease in intestine Non-small cell lung cancer recurrent Infertility male Hairy cell leukaemia recurrent Pulmonary tuberculosis Chordoma Biotinidase deficiency Conjunctivitis allergic Myelofibrosis Neonatal asphyxia Non-Hodgkin's lymphoma refractory Laryngeal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Soft tissue sarcoma – Life with Disease Familial haemophagocytic lymphohistiocytosis – Life with Disease Synovial sarcoma recurrent – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Von Willebrand’s disease – Diagnostics Cholangitis sclerosing – Treatment Hypereosinophilic syndrome – Trials in Disease Short-bowel syndrome Burkitt’s lymphoma Sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bosentan Betula Alba Pollen Extract Finasteride Ezabenlimab ENSIFENTRINE Abiraterone Sorafenib Tosilate Palbociclib LUXDEGALUTAMIDE Imgn151 Acetylcysteine Amide Palivizumab Nemtabrutinib Rilzabrutinib Timbetasin Acetate RNMB3 Atidarsagene Autotemcel Estradiol Salmeterol Xinafoate Cl-Ad-Msc-002 More therapies…

    Learn about Your Condition

    Primary hypogonadism Glycogen storage disorder Renal cancer metastatic Small cell lung cancer Shock Deafness Acute hepatic failure Chondroplasty Sjogren's syndrome Varicella Erdheim-Chester disease Thromboangiitis obliterans Ovarian epithelial cancer Oropharyngeal cancer recurrent Uveal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Medical University Of Silesia Katowice Poland

Medical University Of Silesia Katowice Poland

Medykow 16, Katowice, 40-752, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Lisdexamfetamine Dimesylate
    • Methylphenidate Hydrochloride
    Poland

  • Study on Dimethyl Fumarate for Patients with Mild Cognitive Impairment and Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Dimethyl Fumarate
    Poland

  • Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Italy Poland Spain

  • Study on Cannabidiol as Add-on Therapy for Seizures in Patients Aged 1-65 with Tuberous Sclerosis Complex

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Cannabidiol
    Poland

  • Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Crisantaspase
    • Daunorubicin Hydrochloride
    • Hydrocortisone Sodium Succinate
    Austria Belgium Czechia Denmark Finland France +6

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!